Floatz logo

cd7.car/28zeta car t cells

T-cell Acute Lymphoblastic Lymphoma

Institute of Hematology & Blood Diseases Hospital, ChinaCell therapyPhase 1/2Active
CCC
54/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
40/ 100
Competitive Position
95/ 100

Competitive context

45 Active assets in the T-cell Acute Lymphoblastic Lymphoma cohort.

Asset / SponsorPhaseRating
VINCRISTINE SULFATE
Children's Oncology Group
Phase 3BB
ASPARAGINASE
University of Washington
Phase 3BB
PEGASPARGASE
Children's Oncology Group
Phase 3BB
METHOTREXATE
Children's Oncology Group
Phase 3BB
Cyclophosphamide
Children's Oncology Group
Phase 3BB

View all 50 →

Same molecule, other indications

cd7.car/28zeta car t cells is also rated in:

T-cell non-Hodgkin lymphomaDormant
BB
Indicative ·
66 / 100
View asset →
CD7 PositiveDormant
CCC
Indicative ·
53 / 100
View asset →
T-cell acute lymphoblastic leukemiaDormant
CCC
Indicative ·
50 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →